SCHEMBL23015575

SCHEMBL23015575

CCNC(=O)c1cc(I)c(N)cc1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 5/20 0.55
ACHE P22303 3/20 0.55
LMNA P02545 2/20 0.54
CYP1A2 P05177 2/20 0.50
ADRA2A P08913 2/20 0.50
CYP2D6 P10635 2/20 0.50
DRD3 P35462 2/20 0.50
HTR3E A5X5Y0 2/20 0.50
HTR3B O95264 2/20 0.50
HTR3A P46098 2/20 0.50
HTR3D Q70Z44 2/20 0.50
HTR3C Q8WXA8 2/20 0.50
SLC22A1 O15245 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MPO P05164 1/20 0.50
DRD2 P14416 1/20 0.50
ADRA2C P18825 1/20 0.50
DRD4 P21917 1/20 0.50
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23015576 0.87 DRD2 (0.43) HTR4ACHELMNACYP1A2ADRA2A
SCHEMBL3415873 0.83 ADRA2A (0.74) HTR4ACHELMNACYP1A2ADRA2A
SCHEMBL23015581 0.82 ACHE (0.70) HTR4ACHELMNACYP1A2ADRA2A
SCHEMBL3102868 0.82 HTR4 (0.70) HTR4LMNACYP1A2ADRA2ACYP2D6
SCHEMBL2596444 0.80 GAA (0.66) HTR4ACHEALDH1A1RAB9AKDM4E
SCHEMBL24694562 0.79 LMNA (0.63) HTR4ACHELMNACYP1A2ADRA2A
Acetic Acid SCHEMBL5925562 0.79 HTR4 (0.66) HTR4LMNACYP1A2ADRA2ACYP2D6
SCHEMBL12677220 0.78 KDM4E (0.47) HTR4ACHELMNAALDH1A1RAB9A
SCHEMBL7801336 0.78 ALDH1A1 (0.54) HTR4ACHELMNAALDH1A1KDM4E
SCHEMBL22987077 0.78 HTR4 (0.44) HTR4ACHELMNACYP1A2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10925848-B2 Amide derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10925848-B2 Amide derivative IDO1, IDO2, TPH1 HTR4 214/4885ACHE 1162/4885LMNA 3563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.